Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3876353rdf:typepubmed:Citationlld:pubmed
pubmed-article:3876353lifeskim:mentionsumls-concept:C0026769lld:lifeskim
pubmed-article:3876353lifeskim:mentionsumls-concept:C1518997lld:lifeskim
pubmed-article:3876353lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:3876353lifeskim:mentionsumls-concept:C2346711lld:lifeskim
pubmed-article:3876353lifeskim:mentionsumls-concept:C0178587lld:lifeskim
pubmed-article:3876353lifeskim:mentionsumls-concept:C0442739lld:lifeskim
pubmed-article:3876353pubmed:issue6lld:pubmed
pubmed-article:3876353pubmed:dateCreated1985-10-28lld:pubmed
pubmed-article:3876353pubmed:abstractTextFluorescence-activated cell sorter (FACS) analysis was used to quantitate the antigen density of the lymphocyte markers T3, T4, T8, and Leu 7 on the surface of peripheral blood mononuclear cells (MNC) from exacerbating/remitting multiple sclerosis (MS) patients. Serial studies showed that the mean fluoresce intensity for all the markers studied did not change significantly during exacerbations. There was a tendency for a generalized decline in T-cells, evidenced by a drop in both T8+- and T4+-cells; however, these changes were not statistically significant. It appears, therefore, that the lymphocyte markers studied here are not useful as markers of disease activity in exacerbating/remitting MS.lld:pubmed
pubmed-article:3876353pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3876353pubmed:languageenglld:pubmed
pubmed-article:3876353pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3876353pubmed:citationSubsetIMlld:pubmed
pubmed-article:3876353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3876353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3876353pubmed:statusMEDLINElld:pubmed
pubmed-article:3876353pubmed:monthOctlld:pubmed
pubmed-article:3876353pubmed:issn0165-5728lld:pubmed
pubmed-article:3876353pubmed:authorpubmed-author:HirschR LRLlld:pubmed
pubmed-article:3876353pubmed:authorpubmed-author:JohnsonK PKPlld:pubmed
pubmed-article:3876353pubmed:authorpubmed-author:PanitchH SHSlld:pubmed
pubmed-article:3876353pubmed:authorpubmed-author:OrdonezJJlld:pubmed
pubmed-article:3876353pubmed:issnTypePrintlld:pubmed
pubmed-article:3876353pubmed:volume9lld:pubmed
pubmed-article:3876353pubmed:ownerNLMlld:pubmed
pubmed-article:3876353pubmed:authorsCompleteYlld:pubmed
pubmed-article:3876353pubmed:pagination391-8lld:pubmed
pubmed-article:3876353pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3876353pubmed:meshHeadingpubmed-meshheading:3876353-...lld:pubmed
pubmed-article:3876353pubmed:meshHeadingpubmed-meshheading:3876353-...lld:pubmed
pubmed-article:3876353pubmed:meshHeadingpubmed-meshheading:3876353-...lld:pubmed
pubmed-article:3876353pubmed:meshHeadingpubmed-meshheading:3876353-...lld:pubmed
pubmed-article:3876353pubmed:meshHeadingpubmed-meshheading:3876353-...lld:pubmed
pubmed-article:3876353pubmed:meshHeadingpubmed-meshheading:3876353-...lld:pubmed
pubmed-article:3876353pubmed:meshHeadingpubmed-meshheading:3876353-...lld:pubmed
pubmed-article:3876353pubmed:meshHeadingpubmed-meshheading:3876353-...lld:pubmed
pubmed-article:3876353pubmed:year1985lld:pubmed
pubmed-article:3876353pubmed:articleTitleT8 antigen density on peripheral blood lymphocytes remains unchanged during exacerbations of multiple sclerosis.lld:pubmed
pubmed-article:3876353pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3876353pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3876353pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:3876353pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3876353lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3876353lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3876353lld:pubmed